Screener
Maze Therapeutics MAZE Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Maze Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Maze Therapeutics’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:48 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344903
FAQ
- What is Maze Therapeutics's shares (diluted)?
- Maze Therapeutics (MAZE) reported shares (diluted) of 59M in Q2 2026.
- How has Maze Therapeutics's shares (diluted) changed year-over-year?
- Maze Therapeutics's shares (diluted) increased by 34.7% year-over-year, from 43.8M to 59M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Maze Therapeutics's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude